Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells

被引:46
作者
Di Florio, Alessia
Capurso, Gabriele
Milione, Massimo
Panzuto, Francesco
Geremia, Raffaele
Delle Fave, Gianfranco [1 ]
Sette, Claudio
机构
[1] Univ Roma La Sapienza, Sch Med 2, Digest & Liver Dis Unit, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00133 Rome, Italy
[3] IRCCS Fondaz Santa Lucia, Inst Expt Neurosci, Rome, Italy
关键词
D O I
10.1677/erc.1.01318
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic endocrine tumours (PETS) are rare and 'indolent' neoplasms that usually develop metastatic lesions and exhibit poor response to standard medical treatments. Few studies have investigated pathways responsible for PET cell growth and invasion and no alternative therapeutic strategies have been proposed. In a recent microarray analysis for genes up-regulated in PETS, we have described the up-regulation of soluble Src family tyrosine kinases in this neoplasia, which may represent potentially promising candidates for therapy. Herein, we have investigated the expression and function of Src family kinases in PETS and PET cell lines. Western blot analysis indicated that Src is highly abundant in the PET cell lines CM and QGP-1. Immunohistochemistry and Western blot analyses showed that Src is up-regulated also in human PET lesions. Pharmacological inhibition of Src family kinases by the specific inhibitor PP2 strongly interfered with adhesion, spreading and migration of PET cell lines. Accordingly, the actin cytoskeleton was profoundly altered after inhibition of Src kinases, whereas even prolonged incubation with PP2 exerted no effect on cell cycle progression and/or apoptosis of PET cells. A transient increase in tyrosine phosphorylation of a subset of proteins was observed in QGP-1 cells adhering to the plate, with a peak at 75 min after seeding, when approximately 80% of cells were attached. Inhibition of Src kinases caused a dramatic reduction in the phosphorylation of proteins with different molecular weight that were isolated from the cell extracts by anti-phosphotyrosine immunoprecipitation or pull-down with the SH2 domain of Src. Among them, the docking protein p130Cas interacted with Src and is a major substrate of the Src kinases in QGP-1 cells undergoing adhesion. Our results suggest that Src kinases play a specific role during adhesion, spreading and migration of PET cells and may indicate therapeutical approaches directed to limiting the metastatic potential of these cells.
引用
收藏
页码:111 / 124
页数:14
相关论文
共 44 条
[1]   p130Cas mediates the transforming properties of the anaplastic lymphoma kinase [J].
Ambrogio, C ;
Voena, C ;
Manazza, AD ;
Piva, R ;
Riera, L ;
Barberis, L ;
Costa, C ;
Tarone, G ;
Defilippi, P ;
Hirsch, E ;
Erba, EB ;
Mohammed, S ;
Jensen, ON ;
Palestro, G ;
Inghirami, G ;
Chiarle, R .
BLOOD, 2005, 106 (12) :3907-3916
[2]   Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM [J].
Baroni, MG ;
Cavallo, MG ;
Mark, M ;
Monetini, L ;
Stoehrer, B ;
Pozzilli, P .
JOURNAL OF ENDOCRINOLOGY, 1999, 161 (01) :59-68
[3]   Functions of the adapter protein Cas: signal convergence and the determination of cellular responses [J].
Bouton, AH ;
Riggins, RB ;
Bruce-Staskal, PJ .
ONCOGENE, 2001, 20 (44) :6448-6458
[4]   Identification of Src-specific phosphorylation site on focal adhesion kinase: Dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior [J].
Brunton, VG ;
Avizienyte, E ;
Fincham, VJ ;
Serrels, B ;
Metcalf, CA ;
Sawyer, TK ;
Frame, MC .
CANCER RESEARCH, 2005, 65 (04) :1335-1342
[5]   p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-Neu oncogene-dependent breast tumorigenesis [J].
Cabodi, Sara ;
Tinnirello, Agata ;
Di Stefano, Paola ;
Bisaro, Brigitte ;
Ambrosino, Elena ;
Castellano, Isabella ;
Sapino, Anna ;
Arisio, Riccardo ;
Cavallo, Federica ;
Forni, Guido ;
Glukhova, Marina ;
Silengo, Lorenzo ;
Altruda, Fiorella ;
Turco, Emilia ;
Tarone, Guido ;
Defilippi, Paola .
CANCER RESEARCH, 2006, 66 (09) :4672-4680
[6]  
CALALB MB, 1995, MOL CELL BIOL, V15, P954
[7]   Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets [J].
Capurso, G. ;
Lattimore, S. ;
Crnogorac-Jurcevic, T. ;
Panzuto, F. ;
Milione, M. ;
Bhakta, V. ;
Campanini, N. ;
Swift, S. M. ;
Bord, C. ;
Delle Fave, G. ;
Lemoine, N. R. .
ENDOCRINE-RELATED CANCER, 2006, 13 (02) :541-558
[8]   Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas [J].
Capurso, G ;
Crnogorac-Jurcevic, T ;
Milione, M ;
Panzuto, F ;
Campanini, N ;
Dowen, SE ;
Di Florio, A ;
Sette, C ;
Bordi, C ;
Lemoine, NR ;
Delle Fave, G .
NEUROENDOCRINOLOGY, 2005, 81 (05) :311-321
[9]   PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells [J].
Castoria, G ;
Migliaccio, A ;
Bilancio, A ;
Di Domenico, M ;
de Falco, A ;
Lombardi, M ;
Fiorentino, R ;
Varricchio, L ;
Barone, MV ;
Auricchio, F .
EMBO JOURNAL, 2001, 20 (21) :6050-6059
[10]   Cell adhesion and signalling by cadherins and Ig-CAMs in cancer [J].
Cavallaro, U ;
Christofori, G .
NATURE REVIEWS CANCER, 2004, 4 (02) :118-132